* Cardlytics Inc CDLX.OQ reported a quarterly adjusted
loss
of 15 cents per share for the quarter ended January 1, lower
than the same quarter last year, when the company reported EPS
of 1 cents. The mean expectation of five analysts for the
quarter was for a loss of 24 cents per share. Wall Street
expected results to range from -33 cents to -14 cents per share.
* Revenue fell 15.1% to $67.06 million from a year ago;
analysts
expected $57.79 million.
* Cardlytics Inc's reported EPS for the quarter was a loss
of
$2.90.
* The company reported a quarterly loss of $145.18 million.
* Cardlytics Inc shares had risen by 46.6% this quarter and
lost 49.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 5
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the software peer
group
is also "hold"
Wall Street's median 12-month price target for Cardlytics Inc is
$4.00
This summary was machine generated from LSEG data November 7 at
04:08 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.24 -0.15 Beat
Jun. 30 2024 -0.13 -0.15 Missed
Mar. 31 2024 -0.11 -0.09 Beat
Dec. 31 2023 0.12 0.14 Beat